IDEVvsRXL
iShares Core MSCI International Developed Markets ETF against ProShares Ultra Health Care — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | RXL | |
|---|---|---|
| Expense ratio | 0.040% | 0.95% |
| Assets | $34B | $105M |
| Net flow, 1 month | +$1.7B | −$5M |
| Net flow, 1 year | +$7.8B | +$1M |
| Return, YTD | +8.1% | +30.4% |
| Return, 1 year | +10.5% | +45.1% |
| Avg daily volume | 2.4M | 12K |
| Holdings | 2281 | 73 |
| Listed | Mar 21, 2017 | Feb 1, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS